Location: Tampa
Synced from ClinicalTrials.gov · July 28, 2026
Clinical studies recruiting near Tampa
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)
Phase 3 · Investigative Site US029 · Incyte Corporation · NCT06959225To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
Phase 3 · Biomed Testing Facility #BIO-07-33606 · Biomed Industries, Inc. · NCT06840496The PREDICT Registry:
Phase N/A · BayCare Health System · PreludeDx · NCT03448926A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants
Phase 3 · University of South Florida School of Medicine Morsani Cente · Hoffmann-La Roche · NCT06588855Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
Phase 1 · Moffitt Cancer Center · Stelexis BioSciences · NCT06533761A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Moffitt Cancer Center · Janssen Research & Development, LLC · NCT06319820Product Surveillance Registry
Phase N/A · Medtronic · NCT01524276IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)
Phase 1 · H. Lee Moffitt Cancer Center and Research Institute · TuHURA Biosciences, Inc. · NCT06940440Neoadjuvant Darovasertib in Primary Uveal Melanoma
Phase 3 · USF Health Eye Institute · IDEAYA Biosciences · NCT07015190Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
Phase N/A · Moffitt Cancer Center · H. Lee Moffitt Cancer Center and Research Institute · NCT05687188Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis
Phase N/A · H. Lee Moffitt Cancer Center & Research Institute, Inc. · University of Hawaii · NCT05369546NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants W
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06911112Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · Optimum Clinical Trial Group · Philip Morris Products S.A. · NCT07108166A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
Phase 2 · Clinical Trials Management - S · Bluefin Biomedicine, Inc. · NCT07105488Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · St. Joseph's Hospital · Gilead Sciences · NCT05633654A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin)
Phase 1/Phase 2 · Moffitt Cancer Center and Research Institute · Eisai Inc. · NCT04300556MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Adventhealth Surg Ctr Wellswood · Stryker Instruments · NCT03072927Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
Phase 3 · Retina Associates of Florida, LLC · Jaeb Center for Health Research · NCT06790784Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.
NA · University of South Florida · Epitel, Inc. · NCT06027749A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Phase 3 · Axiom Brain Health LLC · Hoffmann-La Roche · NCT07169578A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmo
Phase 2/Phase 3 · Clinical Research Trials of Florida, Inc. · Pfizer · NCT07363694Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
NA · University of South Florida · Insulet Corporation · NCT07579702Exercise Prehabilitation for Locoregional Esophageal Cancer
NA · Moffitt Cancer Center · H. Lee Moffitt Cancer Center and Research Institute · NCT06430346Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Phase 2/Phase 3 · Tampa General Hospital (TGH) - The Stroke Center · DiaMedica Therapeutics Inc · NCT05065216Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cuta
Phase 1 · Moffitt Cancer Center · H. Lee Moffitt Cancer Center and Research Institute · NCT04975152A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Particip
Phase 3 · Moffitt Cancer Center - Magnolia Campus · Bayer · NCT06452277Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippo
Phase 3 · Moffitt Cancer Center-International Plaza · NRG Oncology · NCT04804644Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Phase 3 · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT05877963A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to
Phase 3 · Vantage Clinical Trials · DiscGenics, Inc. · NCT07254806SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
Phase 1 · Moffitt Cancer Center · Verismo Therapeutics · NCT05568680
Look up another city
Look up another condition